Sarepta Therapeutics, Inc. (SRPT)
16.32
-0.44
(-2.66%)
USD |
NASDAQ |
Mar 02, 16:00
16.39
+0.08
(+0.46%)
After-Hours: 16:43
Sarepta Therapeutics Accounts Payable (Quarterly) : 280.84M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Merck & Co., Inc. | 4.404B |
| Pfizer Inc. | 5.24B |
| REGENXBIO, Inc. | 22.27M |
| Keros Therapeutics, Inc. | 2.298M |
| Alnylam Pharmaceuticals, Inc. | 115.72M |